T1	Outcomes 65 76	micronuclei
T2	Outcomes 742 922	Micronucleus levels in peripheral lymphocytes and changes seen after intervention were studied in relation to the MTHFR C677T genotype, basal homocysteine and plasma folate levels.
T3	Outcomes 923 1060	Ferric reducing ability of plasma and concentration of malondialdehyde were measured to assess the antioxidant effect of supplementation.
T4	Outcomes 1177 1226	Micronucleus frequencies and plasma folate levels
T5	Outcomes 1275 1294	Homocysteine levels
T6	Outcomes 1494 1505	micronuclei
T7	Outcomes 1709 1742	ferric reducing ability of plasma
T8	Outcomes 1761 1788	decrease in malondialdehyde
T9	Outcomes 1802 1824	Micronucleus frequency
T10	Outcomes 1978 1989	micronuclei
